Back to search

Article

EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillance

2022-06-23

Abstract excerpt

<h4>ABSTRACT</h4> T cell-activating immunotherapies that produce durable and even curative responses in some malignancies have failed in pancreatic ductal adenocarcinoma (PDAC) due to rampant immune suppression and poor tumor immunogenicity. We and others have demonstrated that induction of cellular senescence and its accompanying senescence-associated secretory phenotype (SASP) can be an effective approach to ac...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0d6fe6a7-e765-541e-8d7b-a8e77eb85684
DOI
10.1101/2022.06.21.495523
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EZH2 inhibition remodels the inflammatory senescence-associated secretory phenotype to potentiate pancreatic cancer immune surveillanceDOI 10.1101/2022.06.21.495523
Select a neighboring publication to make it the new centre.